Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Experimental Hematology & Oncology|October 17, 2022
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromesJunying Wu, Yudi Zhang, Tiejun Qin, et al.
Experimental Hematology & Oncology|May 29, 2015
Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaYajuan Cui, Hongyan Tong, Xin Du, et al.
Experimental Hematology & Oncology|April 30, 2016
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromesGege Feng, Robert Peter Gale, Wen Cui, et al.
British Journal of Haematology|December 28, 2022
Impact of the International Consensus Classification of myelodysplastic syndromesYudi Zhang, Junying Wu, Zefeng Xu, et al.
Genes, Chromosomes & Cancer|October 24, 2017
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromesBing Li, Jinqin Liu, Yujiao Jia, et al.
Pageof 5